Describing the risk factors and deciphering the underlying mechanisms becomes even more complex as the development of FVIII-specific antibodies is not limited to patients with hemophilia A. Natural FVIII-specific autoantibodies have been found in 17% to 19% of healthy individuals [22,23]. Here, F8 is linked to hemophilia A.